Ratiopharm GmbH
- Address
- Graf-Arco-Strasse 3, Donautal
Sponsor Overview
Specializations
Bioequivalence and generic medicine development
Ratiopharm GmbH is involved in clinical research centred on bioequivalence assessment for pharmaceutical products intended for healthy volunteers, with a clear focus on comparing test and reference formulations of established medicines.
- Furosemide formulation comparison
- Oral tablet product equivalence
- Healthy male volunteers
The sponsor’s research activity is directed toward therapeutic areas where diuretic therapy and product interchangeability are relevant, supporting evaluation of generic drug performance in the European regulatory context.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Bioequivalence Study of Furosemide 500 mg Tablets Versus Lasix 500 mg Tablets in Healthy Male Volunteers Under Fasting Conditions |  Romania | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Female Urogenital Diseases and Pregnancy Complications1 trial142 other sponsors
- 2.Male Urogenital Diseases1 trial111 other sponsors
Partnered Research Centres
1 centre- Address
- Str Centru Dn2 92 3, 727046 Cumparatura
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Ratiopharm GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.